A Self-Adjuvanting Large Pore 2D Covalent Organic Framework as a Vaccine Platform

Area of Science:

• Biotechnology
• Materials Science
• Immunology

Background:

• Traditional vaccines using live or inactivated pathogens pose risks and are costly.
• Subunit vaccines offer improved safety but often lack sufficient immunogenicity due to antigen size and short half-life.

Purpose of the Study:

• To introduce PyCOFamide, a 2D covalent organic framework (COF), as a novel platform for enhancing subunit vaccine efficacy.
• To evaluate the immunogenicity of an ovalbumin antigen adsorbed onto PyCOFamide (OVA@COF) compared to free ovalbumin.

Main Methods:

• Adsorption of a model antigen, ovalbumin (OVA), onto a large pore 2D covalent organic framework (PyCOFamide).
• Assessment of humoral and cell-mediated immune responses in vivo.
• Analysis of immune cell activation, antigen-presenting cell trafficking, and adjuvant effects of COF breakdown products.

Main Results:

• OVA@COF significantly enhanced both humoral and cell-mediated immune responses compared to free OVA.
• PyCOFamide acted as an antigen reservoir, promoting antigen-presenting cell migration to lymph nodes.
• Degradation of the COF released monomers that boosted immune cell activation, enhancing overall immunity.

Conclusions:

• PyCOFamide serves as a promising platform for developing safer and more effective subunit vaccines.
• The COF platform enhances immunogenicity through antigen presentation, immune cell trafficking, and adjuvant effects.